Grandis JR - Search Results

1

Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Cassell A, Freilino ML, Lee J, Barr S, Wang L, Panahandeh MC, Thomas SM, Grandis JR. Cassell A, et al. Among authors: grandis jr. Neoplasia. 2012 Nov;14(11):1005-14. doi: 10.1593/neo.121212. Neoplasia. 2012. PMID: 23226094 Free PMC article.

2

The role of peptide growth factors in head and neck carcinoma.

Grandis JR, Tweardy DJ. Grandis JR, et al. Otolaryngol Clin North Am. 1992 Oct;25(5):1105-15. Otolaryngol Clin North Am. 1992. PMID: 1408194 Review.

3

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. Cancer Res. 1993 Aug 1;53(15):3579-84. Cancer Res. 1993. PMID: 8339264

4

TGF-alpha and EGFR in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. J Cell Biochem Suppl. 1993;17F:188-91. doi: 10.1002/jcb.240531027. J Cell Biochem Suppl. 1993. PMID: 8412192 Review.

5

Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line.

Grandis JR, Zeng Q, Drenning SD, Tweardy DJ. Grandis JR, et al. Int J Oncol. 1998 Aug;13(2):375-8. doi: 10.3892/ijo.13.2.375. Int J Oncol. 1998. PMID: 9664135

6

STAT signaling in head and neck cancer.

Song JI, Grandis JR. Song JI, et al. Among authors: grandis jr. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.

7

Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

Lango MN, Shin DM, Grandis JR. Lango MN, et al. Among authors: grandis jr. Curr Opin Oncol. 2001 May;13(3):168-75. doi: 10.1097/00001622-200105000-00007. Curr Opin Oncol. 2001. PMID: 11307060 Review.

8

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Song JI, et al. Among authors: grandis jr. Cancer Res. 2001 Aug 1;61(15):5919-25. Cancer Res. 2001. PMID: 11479234

9

Differential function of STAT5 isoforms in head and neck cancer growth control.

Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR. Leong PL, et al. Among authors: grandis jr. Oncogene. 2002 Apr 25;21(18):2846-53. doi: 10.1038/sj.onc.1205385. Oncogene. 2002. PMID: 11973644

10

EGFR-mediated cell cycle regulation.

Lui VW, Grandis JR. Lui VW, et al. Among authors: grandis jr. Anticancer Res. 2002 Jan-Feb;22(1A):1-11. Anticancer Res. 2002. PMID: 12017269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters